Literature DB >> 21852075

Clinical parameters of circadian rhythms in affective disorders.

Jan Scott1.   

Abstract

Many affective disorders show episode cycling and the classic symptoms of these disorders show rhythmicity, such as diurnal variation in mood. There are several plausible stress-vulnerability models that suggest links between these observed phenomena and the circadian system. For example, an individual with increased sensitivity to social rhythm disruption may be more at risk of circadian rhythm (CR) dysregulation. Furthermore, there are hypothesized neurobiological mechanisms that may explain how CR dysregulation might lead to sleep, activation, and mood changes in unipolar and bipolar disorders. There are gaps in our understanding, but this paper highlights that clinical measures of sleep and activation are increasingly useful for monitoring the onset and course of affective disorders. Also, evidence suggests that CR disruptions may represent core elements not simply epiphenomena of affective disorders.
Copyright © 2011 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21852075     DOI: 10.1016/j.euroneuro.2011.07.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Cognitive deficits in bipolar disorder: from acute episode to remission.

Authors:  J Volkert; M A Schiele; Julia Kazmaier; Friederike Glaser; K C Zierhut; J Kopf; S Kittel-Schneider; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-26       Impact factor: 5.270

2.  Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study.

Authors:  Michele Fornaro; Michael J McCarthy; Domenico De Berardis; Concetta De Pasquale; Massimo Tabaton; Matteo Martino; Salvatore Colicchio; Carlo Ignazio Cattaneo; Emanuela D'Angelo; Pantaleo Fornaro
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-15       Impact factor: 2.570

3.  Biological rhythm disturbance in remitted bipolar patients.

Authors:  Adriane R Rosa; Mercè Comes; Carla Torrent; Brisa Solè; Maria Reinares; Isabella Pachiarotti; Manel Salamero; Flávio Kapczinski; Francesc Colom; Eduard Vieta
Journal:  Int J Bipolar Disord       Date:  2013-06-13

Review 4.  The Neurobiology of Bipolar Disorder: An Integrated Approach.

Authors:  Ather Muneer
Journal:  Chonnam Med J       Date:  2016-01-19

5.  A pilot study to determine whether combinations of objectively measured activity parameters can be used to differentiate between mixed states, mania, and bipolar depression.

Authors:  Jan Scott; Arne E Vaaler; Ole Bernt Fasmer; Gunnar Morken; Karoline Krane-Gartiser
Journal:  Int J Bipolar Disord       Date:  2017-03-01

Review 6.  Efficacy and tolerability of agomelatine in the treatment of depression.

Authors:  Blanka Kores Plesničar
Journal:  Patient Prefer Adherence       Date:  2014-05-02       Impact factor: 2.711

Review 7.  Telemonitoring with respect to mood disorders and information and communication technologies: overview and presentation of the PSYCHE project.

Authors:  Hervé Javelot; Anne Spadazzi; Luisa Weiner; Sonia Garcia; Claudio Gentili; Markus Kosel; Gilles Bertschy
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

8.  Sleep problems in bipolar disorders: more than just insomnia.

Authors:  M K Steinan; J Scott; T V Lagerberg; I Melle; O A Andreassen; A E Vaaler; G Morken
Journal:  Acta Psychiatr Scand       Date:  2015-11-21       Impact factor: 6.392

9.  Dysregulation of objectively assessed 24-hour motor activity patterns as a potential marker for bipolar I disorder: results of a community-based family study.

Authors:  H Shou; L Cui; I Hickie; D Lameira; F Lamers; J Zhang; C Crainiceanu; V Zipunnikov; K R Merikangas
Journal:  Transl Psychiatry       Date:  2017-08-22       Impact factor: 6.222

Review 10.  Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings.

Authors:  Giselli Scaini; Samira S Valvassori; Alexandre P Diaz; Camila N Lima; Deborah Benevenuto; Gabriel R Fries; Joao Quevedo
Journal:  Braz J Psychiatry       Date:  2020 Sep-Oct       Impact factor: 2.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.